Regeneron Pharmaceuticals (NASDAQ:REGN) Upgraded at Canaccord Genuity Group
Canaccord Genuity Group upgraded shares of Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) from a hold rating to a strong-buy rating in a research note published on Tuesday,Zacks.com reports. Several other equities research analysts have also recently commented on REGN. JPMorgan Chase & Co. cut their price target on shares of Regeneron Pharmaceuticals from $1,100.00 to […]
Canaccord Genuity Group upgraded shares of Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) from a hold rating to a strong-buy rating in a research note published on Tuesday,Zacks.com reports. Several other equities research analysts have also recently commented on REGN. JPMorgan Chase & Co. cut their price target on shares of Regeneron Pharmaceuticals from $1,100.00 to […]
